Mathis Heydtmann

3.8k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Mathis Heydtmann is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Mathis Heydtmann has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 14 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Mathis Heydtmann's work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (10 papers) and Alcohol Consumption and Health Effects (5 papers). Mathis Heydtmann is often cited by papers focused on Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (10 papers) and Alcohol Consumption and Health Effects (5 papers). Mathis Heydtmann collaborates with scholars based in United Kingdom, United States and Spain. Mathis Heydtmann's co-authors include David Adams, Stefan G. Hübscher, Patricia F. Lalor, Vanessa Hebditch, James Neuberger, Judith I. Wyatt, Jai V. Patel, Coral Hollywood, Salil Karkhanis and Susan Davies and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Mathis Heydtmann

30 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology

2020 229 citations James Neuberger, Jai V. Patel et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathis Heydtmann United Kingdom	12	672	559	250	226	141	31	1.1k
Richard Taubert Germany	24	924 1.4×	609 1.1×	452 1.8×	405 1.8×	113 0.8×	77	1.7k
Hülya Çetınkaya Türkiye	17	330 0.5×	472 0.8×	162 0.6×	115 0.5×	139 1.0×	48	989
Richard Standish United Kingdom	14	806 1.2×	942 1.7×	284 1.1×	77 0.3×	95 0.7×	24	1.3k
Michela Emma Burlone Italy	15	689 1.0×	601 1.1×	129 0.5×	86 0.4×	198 1.4×	42	1.1k
Yukako Shintani‐Domoto Japan	14	482 0.7×	515 0.9×	146 0.6×	64 0.3×	153 1.1×	63	1.2k
T. Poralla Germany	19	372 0.6×	382 0.7×	220 0.9×	168 0.7×	92 0.7×	56	973
Vincent Leroy France	17	636 0.9×	545 1.0×	112 0.4×	59 0.3×	112 0.8×	41	945
Claudia Shorthouse Australia	6	868 1.3×	924 1.7×	96 0.4×	219 1.0×	63 0.4×	7	1.3k
Klaus Boeker Germany	14	686 1.0×	647 1.2×	251 1.0×	34 0.2×	179 1.3×	30	1.0k
Filoména Conti France	17	481 0.7×	331 0.6×	272 1.1×	141 0.6×	70 0.5×	35	868

Countries citing papers authored by Mathis Heydtmann

Since Specialization

Citations

This map shows the geographic impact of Mathis Heydtmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathis Heydtmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathis Heydtmann more than expected).

Fields of papers citing papers by Mathis Heydtmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathis Heydtmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathis Heydtmann. The network helps show where Mathis Heydtmann may publish in the future.

Co-authorship network of co-authors of Mathis Heydtmann

This figure shows the co-authorship network connecting the top 25 collaborators of Mathis Heydtmann. A scholar is included among the top collaborators of Mathis Heydtmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathis Heydtmann. Mathis Heydtmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Brien, Niamh L., Sally I. Sharp, Irene Guerrini, et al.. (2022). SLC19A1 Genetic Variation Leads to Altered Thiamine Diphosphate Transport: Implications for the Risk of Developing Wernicke–Korsakoff’s Syndrome. Alcohol and Alcoholism. 57(5). 581–588. 6 indexed citations

Forrest, Ewan, et al.. (2021). Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management. Journal of Clinical Pathology. 75(7). 498–502. 2 indexed citations

Neuberger, James, Jai V. Patel, Helen Caldwell, et al.. (2020). Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 69(8). 1382–1403. 229 indexed citations breakdown →

Thygesen, Johan H., Niamh L. O’Brien, Mathis Heydtmann, et al.. (2020). The influence of regression models on genome-wide association studies of alcohol dependence: a comparison of binary and quantitative analyses. Psychiatric Genetics. 31(1). 13–20. 3 indexed citations

Boyle, Alison, Fiona Marra, T. Ritchíe, et al.. (2019). Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis. Journal of Viral Hepatitis. 27(4). 371–375. 4 indexed citations

Cooney, Gary, Mathis Heydtmann, & Iain Smith. (2019). Baclofen and the Alcohol Withdrawal Syndrome-A Short Review. Frontiers in Psychiatry. 9. 773–773. 20 indexed citations

Marra, Fiona, Edgar J.G. Peters, Mathis Heydtmann, et al.. (2018). 8 weeks sofosbuvir/velpatasvir in genotype 3 patients with significant fibrosis: Highly effective amongst an OST cohort. Journal of Hepatology. 68. S20–S20. 2 indexed citations

Marra, Fiona, Ray Fox, Catherine Fleming, et al.. (2017). Successful management of drug interactions with ritonavir-containing hepatitis C virus regimens in routine clinical practice. Journal of Hepatology. 66(1). S314–S315. 1 indexed citations

Bouttell, Janet, James Lewsey, Claudia Geue, et al.. (2016). The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011. PLoS ONE. 11(10). e0162980–e0162980. 10 indexed citations

10.

Thomson, Emma C., Shalini Datta, Raymond G. Fox, et al.. (2016). Efficacy of Sofosbuvir/Ledipasvir in Treating Genotype 1 and 4 Hepatitis C for 8/12 Weeks: Results from a Difficult to Treat Cohort. Journal of Hepatology. 64(2). S805–S805. 1 indexed citations

11.

Heydtmann, Mathis, et al.. (2015). Tailored dose baclofen in patients with alcoholic liver disease: A case series with 2-year follow-up of hospitalisation. Addiction Research & Theory. 23(6). 510–517. 9 indexed citations

12.

Heydtmann, Mathis & David Adams. (2008). Chemokines in the immunopathogenesis of hepatitis C infection #. Hepatology. 49(2). 676–688. 110 indexed citations

13.

García‐Pagán, Juan Carlos, Mathis Heydtmann, S. Raffa, et al.. (2008). TIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients. Gastroenterology. 135(3). 808–815. 219 indexed citations

14.

Raffa, S., Mathis Heydtmann, Aurélie Plessier, et al.. (2007). [83] TREATMENT OF BUDD CHIARI SYNDROME WITH TIPS. LONG-TERM RESULTS IN 124 PATIENTS AND EVALUATION OF PROGNOSTIC FACTORS. Journal of Hepatology. 46. S36–S37. 1 indexed citations

15.

Heydtmann, Mathis, Debbie L. Hardie, Philip L. Shields, et al.. (2006). Detailed Analysis of Intrahepatic CD8 T Cells in the Normal and Hepatitis C-Infected Liver Reveals Differences in Specific Populations of Memory Cells with Distinct Homing Phenotypes. The Journal of Immunology. 177(1). 729–738. 41 indexed citations

16.

Heydtmann, Mathis, et al.. (2006). Pegylated Interferon Alpha-2b for Patients with HCV Recurrence and Graft Fibrosis Following Liver Transplantation. American Journal of Transplantation. 6(4). 825–833. 27 indexed citations

17.

Heydtmann, Mathis, et al.. (2005). CXC Chemokine Ligand 16 Promotes Integrin-Mediated Adhesion of Liver-Infiltrating Lymphocytes to Cholangiocytes and Hepatocytes within the Inflamed Human Liver. The Journal of Immunology. 174(2). 1055–1062. 189 indexed citations

18.

Heydtmann, Mathis. (2002). The nature of truth: Simpson's Paradox and the limits of statistical data. QJM. 95(4). 247–249. 15 indexed citations

19.

Heydtmann, Mathis, et al.. (2002). Understanding selective trafficking of lymphocyte subsets. Gut. 50(2). 150–152. 22 indexed citations

20.

Heydtmann, Mathis, Philip Shields, Geoffrey W. McCaughan, & David Adams. (2001). Cytokines and chemokines in the immune response to hepatitis C infection. Current Opinion in Infectious Diseases. 14(3). 279–287. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact